Drug safety alert issued on painkiller Meftal
The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert advising healthcare professionals and patients to monitor adverse reactions of painkiller Meftal, commonly used for menstrual cramps and rheumatoid arthritis. The mefenamic acid painkiller is prescribed in the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhoea, mild to moderate pain, inflammation, fever and dental pain. The alert stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database revealed drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome.
If such reaction is encountered, the alert advised, people should report the matter to the national coordination centre of the PvPI under the commission by filing a form on the website - www.Ipc.Gov.In - or through android mobile app ADR PvPI and PvPI Helpline No. 1800-180-3024, it said.
AOMSI’s 47th annual conference held
The 47th Annual Conference of the Association of Oral and Maxillofacial Surgeons of India (AOMSI) was held here based on the theme “Teaming Experience with Evidence.” The delegates explored current and innovative solutions in oral and maxillofacial surgery, discussed important topics like jaw surgery, oral cancer, fractures, craniofacial anomalies, orofacial pathology etc. Conference Secretary Dr. Manjunath Rai, Organizing Chairman Dr. Ashish Gupta , Organizing Secretary Dr. Atul Sharma, Joint Organizing Secretary Dr. Imran Khan and Scientific Chairman Dr. Rohit Chandra, provided a serious platform for discussion of groundbreaking ideas and progress in the field. Chief guest was Dr. Rajiv Bahl, Director General of the Indian Council of Medical Research, according to a statement here.
Vibcare Healthcare’s manufacturing facility in Haryana
Vibcare Healthcare, a pharma firm has opened its state-of-the-art manufacturing facility for general tablets, liquids, capsules, and ointments in Panchkula, Haryana. Spread over 5 acres land, the Rs 40-crore worth facility adheres to the highest international standards, including EU GMP, PIC/S, and UKMHRA GMP, reinforcing Vibcare Healthcare's commitment to global quality benchmarks and healthcare accessibility worldwide, said Siddharth Singhal, CEO of Vibcare Healthcare.
Surya Hospitals heartwarming walkathon for kids
On World Premature Day and International Day of Persons with Disabilities on December 3, Surya Hospitals, Santacruz, brought smiles to over 250 children aged 11 months to 14 years with a special walkathon. Dr. Bhupendra Avasthi, Managing Director, Surya Hospitals urged families to prioritize outdoor play for children. "Put away screens and play," he said, emphasizing the hospital's approach to overall child health. Dr. Bhuvan D., Facility Director, Surya Hospital, stressed the importance of embracing differences and being inclusive in every part of life. "Our commitment to including everyone goes beyond medical care. Every child, no matter their abilities, deserves a chance to grow and succeed," he shared while Dr. Nandkishor Kabra, NICU Director, said, “Premature births bring unique challenges, and our NICU team works hard to give these infants the best care. Today, we celebrate not just their survival but their growth and development.”
USFDA nod for Methylene Blue Injection
Zydus Lifesciences Limited has announced that it has received the final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Methylene Blue Injection, 10mg/2ml and 50mg/5ml. Zydus’ Methylene Blue Injection, 10mg/2ml and 50mg/5ml. generic version of the Reference Listed Drug (RLD) ProvayBlue Injection. The majority of current market usage is still on the ampoule presentation whereas Zydus is offering a generic version of Methylene Blue injection in vial presentation. From a hospital perspective, vial presentation is an affordable option with significant benefit and advantage. Vial presentation has no risk of Glass particulate contamination like in ampoules and provides various benefits like ease of use, handlings and flexible option with reduced dose waste.
